Huy N Trinh, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Offices
- 2
Offices
2 locations · Huy N Trinh MD Gastroenterology Hepatology Inc · San Jose Gastroenterology, Inc.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Trinh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G61514 · Current
Licensed to practise in California · since 1987 · expires 2027-01-31 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Montpelier Surgery Center, IncAmbulatory Surgery Center · San Jose, CA35.2% owner since 2001 · accredited by AAAHCAccreditation Renewed3 inspections · last 2023-05-25
Original Medicare doctor bills
$60,335
Medicare paid this office $60,335 for 319 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 101 | $14,082 | $116 |
| New patient visit (45+ min) | 64 | $9,094 | $142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $8,112 | $213 |
| Short return visit (20+ min) | 90 | $7,464 | $74 |
| New patient visit (30+ min) | 50 | $4,249 | $85 |
See all 10 services
| Return visit (30+ min) | 101 | $14,082 | $116 |
| New patient visit (45+ min) | 64 | $9,094 | $142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 38 | $8,112 | $213 |
| Short return visit (20+ min) | 90 | $7,464 | $74 |
| New patient visit (30+ min) | 50 | $4,249 | $85 |
| Pathology examination of tissue using a microscope, intermediate complexity | 63 | $4,055 | $39 |
| Biopsy of large bowel using a flexible endoscope | 26 | $2,622 | $101 |
| Ultrasound scan of organ tissue for measuring elasticity | 17 | $2,008 | $106 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,691 | $99 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $95 | $5 |
Procedures Medicare counted
| Colonoscopy | 143 | More than 88% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 33 | More than 57% of doctors who do this |
Who their Medicare patients are
319 Original Medicare patients in 2024. Average age 74 · Women 60% · Also on Medicaid 77% · Health risk score 1.10. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 50% · Chronic kidney disease 26% · Coronary heart disease 16% · COPD 10% · Heart failure 8% · Cancer 8% · Atrial fibrillation 8% · Depression 7% · Dementia 4% · Stroke 4%.
The office billed $286,796, Medicare allowed $82,323 and paid $60,335; for 614 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 319 | 614 | 74 | 1.10 | $286,796 | $60,335 |
| 2023 | 363 | 888 | 75 | 1.13 | $294,974 | $81,042 |
| 2022 | 408 | 1,105 | 75 | 1.02 | $352,114 | $100,910 |
| 2021 | 425 | 1,195 | 75 | 1.23 | $375,797 | $104,162 |
| 2020 | 384 | 1,072 | 74 | 1.35 | $313,976 | $93,370 |
| 2019 | 579 | 1,689 | 74 | 1.20 | $537,086 | $157,370 |
| 2018 | 634 | 1,872 | 73 | 1.21 | $573,272 | $169,252 |
| 2017 | 630 | 1,875 | 74 | 1.28 | $520,537 | $161,885 |
| 2016 | 530 | 1,327 | 73 | 1.26 | $422,760 | $131,337 |
| 2015 | 580 | 1,531 | 73 | 1.37 | $453,572 | $145,573 |
| 2014 | 662 | 1,841 | 73 | 1.29 | $447,482 | $172,486 |
| 2013 | 684 | 1,864 | 73 | 1.25 | $359,514 | $185,699 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 173 | $16,280 | $80 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 57 | $12,824 | $225 |
| New patient visit (30+ min) | 77 | $7,364 | $96 |
| Pathology examination of tissue using a microscope, intermediate complexity | 104 | $6,612 | $39 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $6,084 | $203 |
| Complete ultrasound scan of abdomen | 46 | $4,892 | $106 |
| Biopsy of large bowel using a flexible endoscope | 34 | $4,829 | $142 |
| Return visit (30+ min) | 33 | $4,227 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,185 | $91 |
| New patient visit (45+ min) | 22 | $2,990 | $136 |
| Limited ultrasound scan of abdomen | 39 | $2,902 | $74 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $1,637 | $96 |
| New patient visit (15+ min) | 22 | $1,341 | $61 |
| Measurement of liver stiffness | 23 | $668 | $28 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 37 | $149 | $4 |
2022: 15 services
| Short return visit (20+ min) | 187 | $17,513 | $81 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 66 | $15,105 | $229 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $9,644 | $210 |
| Complete ultrasound scan of abdomen | 67 | $8,346 | $118 |
| Limited ultrasound scan of abdomen | 85 | $8,002 | $82 |
| Pathology examination of tissue using a microscope, intermediate complexity | 100 | $6,458 | $38 |
| New patient visit (30+ min) | 61 | $6,119 | $100 |
| Return visit (30+ min) | 37 | $4,937 | $118 |
| New patient visit (45+ min) | 31 | $4,633 | $149 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 43 | $4,083 | $93 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,634 | $146 |
| New patient visit (15+ min) | 41 | $2,512 | $61 |
| Special stained specimen slides to identify organisms including interpretation and report | 19 | $2,498 | $96 |
| Measurement of liver stiffness | 52 | $1,542 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 61 | $264 | $4 |
2021: 18 services
| Short return visit (20+ min) | 205 | $17,698 | $72 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $11,999 | $226 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 45 | $9,533 | $212 |
| Complete ultrasound scan of abdomen | 85 | $9,090 | $106 |
| Limited ultrasound scan of abdomen | 88 | $7,077 | $70 |
| New patient visit (30+ min) | 70 | $6,073 | $87 |
| Pathology examination of tissue using a microscope, intermediate complexity | 96 | $5,800 | $37 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $5,369 | $101 |
| Return visit (30+ min) | 41 | $5,145 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,394 | $183 |
| New patient visit (45+ min) | 24 | $3,541 | $148 |
| Biopsy of large bowel using a flexible endoscope | 26 | $2,951 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,365 | $66 |
| Measurement of liver stiffness | 75 | $2,106 | $28 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $1,712 | $95 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,372 | $86 |
| New patient visit (15+ min) | 20 | $1,151 | $58 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 60 | $261 | $4 |
2020: 16 services
| Short return visit (20+ min) | 222 | $18,710 | $66 |
| Complete ultrasound scan of abdomen | 83 | $10,537 | $121 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 43 | $10,014 | $233 |
| Pathology examination of tissue using a microscope, intermediate complexity | 84 | $7,647 | $49 |
| Limited ultrasound scan of abdomen | 70 | $6,796 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,860 | $211 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,255 | $185 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $4,226 | $103 |
| New patient visit (30+ min) | 44 | $4,033 | $92 |
| Return visit (30+ min) | 37 | $3,818 | $100 |
| New patient visit (45+ min) | 26 | $3,713 | $143 |
| Biopsy of large bowel using a flexible endoscope | 30 | $3,623 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,589 | $66 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,092 | $91 |
| Measurement of liver stiffness | 28 | $1,006 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 63 | $262 | $4 |
2019: 19 services
| Short return visit (20+ min) | 279 | $24,164 | $69 |
| Pathology examination of tissue using a microscope, intermediate complexity | 145 | $20,350 | $69 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | $18,720 | $234 |
| Complete ultrasound scan of abdomen | 77 | $11,441 | $120 |
| Limited ultrasound scan of abdomen | 88 | $10,187 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $9,739 | $212 |
| New patient visit (30+ min) | 88 | $8,193 | $93 |
| Biopsy of large bowel using a flexible endoscope | 75 | $7,818 | $104 |
| Return visit (30+ min) | 65 | $7,528 | $103 |
| New patient visit (45+ min) | 46 | $6,925 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 60 | $5,138 | $84 |
| Special stained specimen slides to identify organisms including interpretation and report | 34 | $4,187 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,655 | $183 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,888 | $206 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,175 | $95 |
| Measurement of liver stiffness | 53 | $2,074 | $39 |
| New patient visit (15+ min) | 13 | $958 | $74 |
| New patient visit (10+ min) | 19 | $719 | $38 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 102 | $456 | $4 |
2018: 19 services
| Short return visit (20+ min) | 291 | $26,706 | $68 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 92 | $21,382 | $232 |
| Pathology examination of tissue using a microscope, intermediate complexity | 184 | $20,457 | $68 |
| New patient visit (30+ min) | 176 | $17,167 | $98 |
| Complete ultrasound scan of abdomen | 73 | $10,978 | $123 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 48 | $9,890 | $206 |
| Biopsy of large bowel using a flexible endoscope | 80 | $9,568 | $120 |
| Limited ultrasound scan of abdomen | 82 | $8,991 | $90 |
| New patient visit (45+ min) | 55 | $8,367 | $152 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $7,641 | $97 |
| Return visit (30+ min) | 44 | $4,647 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,456 | $182 |
| Special stained specimen slides to identify organisms including interpretation and report | 27 | $3,024 | $101 |
| Measurement of liver stiffness | 62 | $2,498 | $40 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,167 | $83 |
| New patient visit (15+ min) | 13 | $861 | $66 |
| New patient visit (10+ min) | 24 | $822 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 124 | $528 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 32 | $382 | $12 |
2017: 21 services
| Short return visit (20+ min) | 262 | $23,429 | $67 |
| Pathology examination of tissue using a microscope, intermediate complexity | 176 | $19,207 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 79 | $18,548 | $232 |
| Limited ultrasound scan of abdomen | 106 | $12,383 | $88 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 53 | $11,152 | $210 |
| Biopsy of large bowel using a flexible endoscope | 78 | $11,025 | $141 |
| New patient visit (45+ min) | 57 | $8,366 | $147 |
| New patient visit (30+ min) | 73 | $7,176 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $6,694 | $108 |
| Complete ultrasound scan of abdomen | 50 | $6,370 | $123 |
| Return visit (30+ min) | 56 | $6,282 | $101 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,164 | $181 |
| Special stained specimen slides to identify organisms including interpretation and report | 41 | $4,348 | $99 |
| New patient visit (10+ min) | 73 | $2,944 | $40 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,791 | $107 |
| New patient visit (15+ min) | 30 | $1,992 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,231 | $65 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 71 | $796 | $11 |
| Measurement of liver stiffness | 19 | $739 | $39 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 58 | $702 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 128 | $586 | $5 |
2016: 18 services
| Short return visit (20+ min) | 215 | $19,487 | $67 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $16,193 | $235 |
| Pathology examination of tissue using a microscope, intermediate complexity | 132 | $14,781 | $71 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 61 | $13,160 | $216 |
| Limited ultrasound scan of abdomen | 104 | $11,246 | $89 |
| Biopsy of large bowel using a flexible endoscope | 64 | $7,116 | $111 |
| Complete ultrasound scan of abdomen | 60 | $7,051 | $116 |
| New patient visit (45+ min) | 42 | $6,274 | $149 |
| New patient visit (30+ min) | 63 | $6,042 | $96 |
| Return visit (30+ min) | 38 | $4,190 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $4,028 | $103 |
| Special stained specimen slides to identify organisms including interpretation and report | 33 | $3,397 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,704 | $180 |
| New patient visit (10+ min) | 57 | $2,294 | $40 |
| New patient visit (15+ min) | 30 | $2,117 | $71 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,737 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $965 | $64 |
| Measurement of liver stiffness | 16 | $436 | $27 |
2015: 22 services
| Short return visit (20+ min) | 229 | $19,876 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 67 | $17,997 | $269 |
| Pathology examination of tissue using a microscope, intermediate complexity | 138 | $12,803 | $59 |
| Limited ultrasound scan of abdomen | 97 | $11,532 | $89 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 46 | $10,473 | $228 |
| Biopsy of large bowel using a flexible endoscope | 59 | $8,895 | $151 |
| Complete ultrasound scan of abdomen | 52 | $6,893 | $123 |
| Return visit (30+ min) | 58 | $6,274 | $98 |
| New patient visit (30+ min) | 67 | $6,243 | $93 |
| New patient visit (45+ min) | 41 | $6,036 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $5,904 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,608 | $181 |
| Special stained specimen slides to identify organisms including interpretation and report | 43 | $4,076 | $93 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $3,155 | $166 |
| New patient visit (10+ min) | 85 | $3,153 | $37 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,231 | $101 |
| New patient visit (15+ min) | 31 | $1,912 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,682 | $65 |
| Measurement of liver stiffness | 44 | $1,529 | $35 |
| Special stained specimen slides to examine tissue including interpretation and report | 14 | $920 | $61 |
| Short return visit | 12 | $421 | $35 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $373 | $16 |
2014: 22 services
| Short return visit (20+ min) | 272 | $24,367 | $63 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 63 | $15,174 | $241 |
| Limited ultrasound scan of abdomen | 108 | $14,741 | $102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $14,617 | $271 |
| Complete ultrasound scan of abdomen | 78 | $11,064 | $137 |
| Biopsy of large bowel using a flexible endoscope | 48 | $9,433 | $197 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | $9,425 | $118 |
| Pathology examination of tissue using a microscope, intermediate complexity | 156 | $7,565 | $33 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,375 | $180 |
| New patient visit (45+ min) | 47 | $6,904 | $147 |
| Return visit (30+ min) | 68 | $6,859 | $90 |
| New patient visit (30+ min) | 76 | $6,823 | $90 |
| Diagnostic exam of large bowel using a flexible endoscope | 39 | $6,503 | $167 |
| Special stained specimen slides to identify organisms including interpretation and report | 73 | $5,478 | $69 |
| Special stained specimen slides to examine tissue including interpretation and report | 73 | $4,796 | $56 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,613 | $241 |
| New patient visit (15+ min) | 49 | $3,096 | $63 |
| New patient visit (10+ min) | 81 | $2,857 | $35 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,648 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,114 | $62 |
| Short return visit | 22 | $830 | $36 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $537 | $19 |
2013: 22 services
| Short return visit (20+ min) | 282 | $26,901 | $66 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 78 | $20,859 | $267 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 67 | $16,193 | $242 |
| Limited ultrasound scan of abdomen | 95 | $15,050 | $108 |
| Biopsy of large bowel using a flexible endoscope | 57 | $11,006 | $193 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $10,771 | $133 |
| New patient visit (30+ min) | 101 | $9,899 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $8,612 | $176 |
| Pathology examination of tissue using a microscope, intermediate complexity | 179 | $8,370 | $35 |
| New patient visit (45+ min) | 49 | $7,167 | $146 |
| Complete ultrasound scan of abdomen | 47 | $6,515 | $139 |
| Return visit (30+ min) | 50 | $5,845 | $97 |
| New patient visit (15+ min) | 82 | $5,707 | $70 |
| Special stained specimen slides to identify organisms including interpretation and report | 65 | $5,144 | $75 |
| Special stained specimen slides to examine tissue including interpretation and report | 69 | $4,740 | $59 |
| Diagnostic exam of large bowel using a flexible endoscope | 24 | $4,198 | $175 |
| New patient visit (10+ min) | 73 | $2,914 | $40 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,452 | $102 |
| Removal of external hemorrhoids by rubber banding | 13 | $2,198 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,682 | $62 |
| Short return visit | 16 | $756 | $42 |
| Diagnostic exam of lower portion of large bowel using a flexible endoscope | 14 | $473 | $34 |
Medicaid work
$15 in 2024
Medicaid paid $15 for 142 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 25 | $15 |
| Short return visit (20+ min) | 25 | $0 |
| Return visit (30+ min) | 92 | $0 |
| 2024 | 142 | 3 | 27 | $15 |
| 2023 | 347 | 5 | 30 | $284 |
| 2022 | 598 | 8 | 32 | $1,354 |
| 2021 | 675 | 6 | 35 | $2,735 |
| 2020 | 606 | 6 | 46 | $742 |
| 2019 | 534 | 9 | 34 | $2,369 |
| 2018 | 616 | 8 | 30 | $1,526 |
See the largest Medicaid services in earlier years
2023
| ECHO EXAM OF ABDOMEN | 15 | $162 |
| Short return visit (20+ min) | 251 | $76 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 15 | $25 |
| New patient visit (30+ min) | 54 | $22 |
| Ultrasound, abdominal, real time with image documentation; complete | 12 | $0 |
2022
| ECHO EXAM OF ABDOMEN | 117 | $363 |
| Short return visit (20+ min) | 298 | $243 |
| Upper gastrointestinal endoscopy with biopsy | 13 | $234 |
| COLONOSCOPY W/LESION REMOVAL | 14 | $217 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 53 | $95 |
| TISSUE EXAM BY PATHOLOGIST | 25 | $91 |
| New patient visit (30+ min) | 25 | $63 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 53 | $47 |
2021
| ECHO EXAM OF ABDOMEN | 96 | $877 |
| Short return visit (20+ min) | 318 | $647 |
| Ultrasound, abdominal, real time with image documentation; complete | 82 | $521 |
| New patient visit (30+ min) | 55 | $441 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 88 | $242 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 36 | $6 |
2020
| Short return visit (20+ min) | 366 | $351 |
| ECHO EXAM OF ABDOMEN | 116 | $336 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 44 | $45 |
| Ultrasound, abdominal, real time with image documentation; complete | 54 | $10 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 14 | $0 |
| New patient visit (30+ min) | 12 | $0 |
2019
| COLONOSCOPY W/LESION REMOVAL | 24 | $895 |
| Upper gastrointestinal endoscopy with biopsy | 14 | $875 |
| COLONOSCOPY AND BIOPSY | 18 | $327 |
| Short return visit (20+ min) | 276 | $145 |
| ECHO EXAM OF ABDOMEN | 32 | $67 |
| New patient visit (30+ min) | 103 | $50 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 26 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 29 | $0 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $0 |
2018
| COLONOSCOPY W/LESION REMOVAL | 12 | $447 |
| COLONOSCOPY AND BIOPSY | 24 | $374 |
| Short return visit (20+ min) | 294 | $314 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $213 |
| New patient visit (30+ min) | 208 | $178 |
| TISSUE EXAM BY PATHOLOGIST | 12 | $0 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 13 | $0 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 41 | $0 |
Drugs they prescribed that Part D paid
$1,639,926
Pharmacies billed $1,639,926 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,686) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
674 generic and 1,012 brand-name prescriptions · $1,639,926 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 813 | $1,247,882 | $1,535 |
| Rezdiffra | 36 | $141,631 | $3,934 |
| Baraclude | 61 | $84,759 | $1,389 |
| Entecavir | 204 | $66,074 | $324 |
| Mesalamine | 23 | $14,926 | $649 |
See all 14 drugs
| Vemlidy | 813 | $1,247,882 | $1,535 |
| Rezdiffra | 36 | $141,631 | $3,934 |
| Baraclude | 61 | $84,759 | $1,389 |
| Entecavir | 204 | $66,074 | $324 |
| Mesalamine | 23 | $14,926 | $649 |
| Tenofovir Disoproxil | 68 | $10,893 | $160 |
| Sod Sulf-Potass Sulf-Mag Sulf | 137 | $8,656 | $63 |
| Ursodiol | 13 | $4,860 | $374 |
| Gavilyte-C | 53 | $1,062 | $20 |
| Gavilyte-G | 65 | $944 | $15 |
| Peg 3350-Electrolyte | 28 | $595 | $21 |
| Peg-3350 and Electrolytes | 15 | $230 | $15 |
| Omeprazole | 52 | $208 | $4 |
| Imipramine | 18 | $72 | $4 |
Year by year
| 2024 | 1,686 | 496 | 0% (0) | 60% | $1,639,926 |
| 2023 | 2,173 | 525 | 0% (0) | 67% | $2,120,180 |
| 2022 | 2,370 | 493 | 0% (0) | 72% | $2,198,009 |
| 2021 | 2,535 | 525 | 0% (0) | 73% | $2,306,883 |
| 2020 | 2,434 | 449 | 0% (0) | 68% | $1,964,827 |
| 2019 | 2,420 | 543 | 0% (0) | 67% | $2,262,103 |
| 2018 | 2,081 | 435 | 0% (0) | 64% | $2,124,546 |
| 2017 | 2,085 | 460 | 0% (0) | 65% | $2,973,280 |
| 2016 | 2,146 | 516 | None | 65% | $2,799,797 |
| 2015 | 2,037 | 522 | 0% (0) | 75% | $5,122,222 |
| 2014 | 1,973 | 498 | None | 77% | $4,528,565 |
| 2013 | 1,759 | 494 | 0% (0) | 75% | $1,252,492 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Vemlidy | 1,186 | $1,696,388 | $1,430 |
| Baraclude | 107 | $158,828 | $1,484 |
| Entecavir | 241 | $87,791 | $364 |
| Viread | 15 | $19,941 | $1,329 |
| Mesalamine | 16 | $11,412 | $713 |
| Sod Sulf-Potass Sulf-Mag Sulf | 142 | $11,158 | $79 |
| Ursodiol | 18 | $4,189 | $233 |
| Tenofovir Disoproxil | 54 | $4,103 | $76 |
| Suprep | 34 | $3,986 | $117 |
| Clenpiq | 11 | $1,910 | $174 |
| Gavilyte-C | 49 | $993 | $20 |
| Gavilyte-G | 44 | $878 | $20 |
| Omeprazole | 64 | $849 | $13 |
| Peg 3350-Electrolyte | 29 | $789 | $27 |
| Simvastatin | 15 | $454 | $30 |
| Peg-3350 and Electrolytes | 14 | $371 | $27 |
| Imipramine | 13 | $126 | $10 |
2022: 17 drugs
| Vemlidy | 1,285 | $1,739,072 | $1,353 |
| Baraclude | 139 | $202,204 | $1,455 |
| Entecavir | 312 | $87,244 | $280 |
| Viread | 27 | $34,633 | $1,283 |
| Suprep | 164 | $18,461 | $113 |
| Mesalamine | 14 | $11,712 | $837 |
| Tenofovir Disoproxil | 84 | $7,069 | $84 |
| Sod Sulf-Potass Sulf-Mag Sulf | 46 | $3,667 | $80 |
| Ursodiol | 11 | $2,311 | $210 |
| Mycophenolate Mofetil | 13 | $588 | $45 |
| Gavilyte-C | 27 | $507 | $19 |
| Omeprazole | 59 | $471 | $8 |
| Peg 3350-Electrolyte | 16 | $315 | $20 |
| Gavilyte-G | 12 | $208 | $17 |
| Atorvastatin | 12 | $193 | $16 |
| Simvastatin | 15 | $185 | $12 |
| Furosemide | 13 | $102 | $8 |
2021: 18 drugs
| Vemlidy | 1,343 | $1,668,065 | $1,242 |
| Baraclude | 155 | $218,279 | $1,408 |
| Entecavir | 353 | $86,931 | $246 |
| Viread | 27 | $34,282 | $1,270 |
| Suprep | 244 | $26,319 | $108 |
| Mesalamine | 20 | $14,215 | $711 |
| Tenofovir Disoproxil | 92 | $10,087 | $110 |
| Dexilant | 12 | $3,914 | $326 |
| Mycophenolate Mofetil | 13 | $646 | $50 |
| Peg 3350-Electrolyte | 26 | $446 | $17 |
| Omeprazole | 38 | $358 | $9 |
| Spironolactone | 14 | $338 | $24 |
| Atorvastatin | 13 | $263 | $20 |
| Simvastatin | 18 | $203 | $11 |
| Gavilyte-C | 11 | $170 | $15 |
| Peg-3350 and Electrolytes | 14 | $169 | $12 |
| Pantoprazole | 12 | $155 | $13 |
| Propranolol | 11 | $98 | $9 |
2020: 18 drugs
| Vemlidy | 1,217 | $1,436,745 | $1,181 |
| Baraclude | 163 | $228,139 | $1,400 |
| Entecavir | 403 | $89,209 | $221 |
| Linzess | 50 | $28,669 | $573 |
| Xifaxan | 12 | $22,245 | $1,854 |
| Viread | 14 | $17,211 | $1,229 |
| Suprep | 150 | $15,508 | $103 |
| Mesalamine | 14 | $14,152 | $1,011 |
| Canasa | 11 | $12,701 | $1,155 |
| Tenofovir Disoproxil | 69 | $7,151 | $104 |
| Ursodiol | 11 | $3,560 | $324 |
| Mycophenolate Mofetil | 13 | $915 | $70 |
| Omeprazole | 77 | $515 | $7 |
| Gavilyte-G | 25 | $363 | $15 |
| Peg 3350-Electrolyte | 19 | $347 | $18 |
| Pantoprazole | 15 | $242 | $16 |
| Peg-3350 and Electrolytes | 11 | $131 | $12 |
| Simvastatin | 23 | $129 | $6 |
2019: 18 drugs
| Vemlidy | 1,085 | $1,216,235 | $1,121 |
| Epclusa | 18 | $448,662 | $24,926 |
| Baraclude | 148 | $210,561 | $1,423 |
| Entecavir | 441 | $130,371 | $296 |
| Linzess | 60 | $30,097 | $502 |
| Viread | 13 | $15,125 | $1,163 |
| Suprep | 149 | $14,679 | $99 |
| Tenofovir Disoproxil | 53 | $5,717 | $108 |
| Moviprep | 26 | $2,715 | $104 |
| Peg 3350-Electrolyte | 53 | $869 | $16 |
| Gavilyte-N | 44 | $807 | $18 |
| Omeprazole | 90 | $774 | $9 |
| Gavilyte-G | 24 | $360 | $15 |
| Peg-3350 and Electrolytes | 19 | $235 | $12 |
| Spironolactone | 17 | $185 | $11 |
| Pantoprazole | 14 | $163 | $12 |
| Polyethylene Glycol 3350 | 12 | $156 | $13 |
| Simvastatin | 16 | $77 | $5 |
2018: 18 drugs
| Vemlidy | 755 | $812,767 | $1,077 |
| Entecavir | 435 | $286,881 | $659 |
| Epclusa | 11 | $283,870 | $25,806 |
| Baraclude | 199 | $283,380 | $1,424 |
| Viread | 60 | $59,604 | $993 |
| Linzess | 67 | $28,831 | $430 |
| Suprep | 94 | $8,740 | $93 |
| Tenofovir Disoproxil | 36 | $8,480 | $236 |
| Dexilant | 20 | $7,520 | $376 |
| Amitiza | 14 | $3,926 | $280 |
| Moviprep | 13 | $1,304 | $100 |
| Peg 3350-Electrolyte | 48 | $984 | $21 |
| Gavilyte-N | 44 | $896 | $20 |
| Polyethylene Glycol 3350 | 38 | $670 | $18 |
| Omeprazole | 84 | $620 | $7 |
| Gavilyte-C | 13 | $177 | $14 |
| Spironolactone | 11 | $101 | $9 |
| Simvastatin | 18 | $45 | $3 |
2017: 20 drugs
| Epclusa | 36 | $900,898 | $25,025 |
| Viread | 373 | $379,815 | $1,018 |
| Baraclude | 259 | $369,326 | $1,426 |
| Vemlidy | 357 | $359,533 | $1,007 |
| Entecavir | 452 | $329,063 | $728 |
| Nexavar | 15 | $254,420 | $16,961 |
| Truvada | 12 | $19,157 | $1,596 |
| Canasa | 12 | $11,691 | $974 |
| Dexilant | 25 | $8,554 | $342 |
| Linzess | 24 | $8,503 | $354 |
| Moviprep | 66 | $6,155 | $93 |
| Suprep | 68 | $5,961 | $88 |
| Amitiza | 11 | $1,967 | $179 |
| Gavilyte-N | 68 | $1,337 | $20 |
| Nadolol | 14 | $1,197 | $85 |
| Peg 3350-Electrolyte | 34 | $584 | $17 |
| Omeprazole | 60 | $371 | $6 |
| Polyethylene Glycol 3350 | 18 | $324 | $18 |
| Gavilyte-C | 16 | $207 | $13 |
| Simvastatin | 12 | $83 | $7 |
2016: 22 drugs
| Viread | 658 | $647,850 | $985 |
| Epclusa | 25 | $626,344 | $25,054 |
| Baraclude | 324 | $419,408 | $1,294 |
| Entecavir | 464 | $415,153 | $895 |
| Nexavar | 16 | $235,272 | $14,704 |
| Truvada | 12 | $17,683 | $1,474 |
| Linzess | 37 | $11,905 | $322 |
| Moviprep | 109 | $9,614 | $88 |
| Dexilant | 24 | $5,854 | $244 |
| Ursodiol | 15 | $2,693 | $180 |
| Amitiza | 13 | $2,199 | $169 |
| Suprep | 24 | $1,997 | $83 |
| Gavilyte-N | 88 | $1,652 | $19 |
| Nadolol | 20 | $1,302 | $65 |
| Peg 3350-Electrolyte | 57 | $1,026 | $18 |
| Trilyte With Flavor Packets | 20 | $369 | $18 |
| Gavilyte-C | 26 | $361 | $14 |
| Balsalazide Disodium | 12 | $305 | $25 |
| Omeprazole | 51 | $260 | $5 |
| Polyethylene Glycol 3350 | 17 | $233 | $14 |
| Peg-3350 and Electrolytes | 12 | $165 | $14 |
| Atorvastatin | 12 | $60 | $5 |
2015: 23 drugs
| Harvoni | 107 | $3,394,712 | $31,726 |
| Baraclude | 572 | $698,910 | $1,222 |
| Viread | 447 | $404,672 | $905 |
| Entecavir | 268 | $261,028 | $974 |
| Nexavar | 17 | $218,819 | $12,872 |
| Truvada | 12 | $16,344 | $1,362 |
| Moviprep | 185 | $14,979 | $81 |
| Ursodiol | 25 | $6,183 | $247 |
| Linzess | 11 | $3,222 | $293 |
| Dexilant | 13 | $2,808 | $216 |
| Amitiza | 12 | $1,930 | $161 |
| Gavilyte-N | 47 | $980 | $21 |
| Balsalazide Disodium | 12 | $708 | $59 |
| Peg 3350-Electrolyte | 35 | $697 | $20 |
| Polyethylene Glycol 3350 | 26 | $587 | $23 |
| Trilyte With Flavor Packets | 28 | $556 | $20 |
| Spironolactone | 15 | $480 | $32 |
| Gavilyte-C | 22 | $338 | $15 |
| Omeprazole | 55 | $260 | $5 |
| Famotidine | 13 | $210 | $16 |
| Peg 3350-Electrolyte | 19 | $197 | $10 |
| Levofloxacin | 16 | $126 | $8 |
| Amoxicillin | 16 | $87 | $5 |
2014: 25 drugs
| Sovaldi | 68 | $1,940,557 | $28,538 |
| Baraclude | 781 | $946,695 | $1,212 |
| Harvoni | 20 | $641,301 | $32,065 |
| Olysio | 18 | $406,015 | $22,556 |
| Viread | 319 | $273,399 | $857 |
| Nexavar | 16 | $177,432 | $11,089 |
| Ribapak | 41 | $37,044 | $904 |
| Truvada | 17 | $22,207 | $1,306 |
| Entecavir | 13 | $12,889 | $991 |
| Moviprep | 65 | $5,303 | $82 |
| Ursodiol | 26 | $4,662 | $179 |
| Dexilant | 19 | $3,492 | $184 |
| Ribasphere | 12 | $2,995 | $250 |
| Peg-3350 | 68 | $1,382 | $20 |
| Gavilyte-N | 59 | $1,169 | $20 |
| Polyethylene Glycol 3350 | 34 | $907 | $27 |
| Balsalazide Disodium | 11 | $810 | $74 |
| Trilyte With Flavor Packets | 38 | $777 | $20 |
| Omeprazole | 85 | $640 | $8 |
| Spironolactone | 20 | $625 | $31 |
| Peg 3350-Electrolyte | 35 | $371 | $11 |
| Gavilyte-C | 24 | $353 | $15 |
| Peg-3350 and Electrolytes | 21 | $283 | $13 |
| Levofloxacin | 19 | $156 | $8 |
| Amoxicillin | 17 | $125 | $7 |
2013: 22 drugs
| Baraclude | 754 | $784,634 | $1,041 |
| Viread | 253 | $210,417 | $832 |
| Nexavar | 14 | $142,864 | $10,205 |
| Pegasys Proclick | 19 | $52,881 | $2,783 |
| Truvada | 23 | $28,805 | $1,252 |
| Dexilant | 36 | $5,608 | $156 |
| Nexium | 14 | $2,971 | $212 |
| Peg-3350 With Flavor Packs | 103 | $2,043 | $20 |
| Trilyte With Flavor Packets | 70 | $1,522 | $22 |
| Omeprazole | 101 | $1,042 | $10 |
| Balsalazide Disodium | 14 | $919 | $66 |
| Gavilyte-N | 41 | $831 | $20 |
| Polyethylene Glycol 3350 | 28 | $801 | $29 |
| Peg 3350-Electrolyte | 46 | $528 | $11 |
| Mometasone Furoate | 16 | $443 | $28 |
| Ursodiol | 11 | $356 | $32 |
| Peg-3350 and Electrolytes | 23 | $340 | $15 |
| Levofloxacin | 24 | $309 | $13 |
| Amoxicillin | 24 | $218 | $9 |
| Gavilyte-C | 14 | $212 | $15 |
| Ranitidine | 16 | $148 | $9 |
| Propranolol | 14 | $93 | $7 |
Money from drug and device companies
$13,642 in 2025
| 2025 | 6 | 14 | $13,180 | $13,642 |
| 2024 | 5 | 30 | $14,820 | $16,540 |
| 2023 | 2 | 15 | $7,100 | $7,479 |
| 2022 | 2 | 19 | $12,855 | $13,392 |
| 2021 | 2 | 34 | $20,265 | $20,725 |
| 2020 | 2 | 27 | $22,020 | $22,805 |
| 2019 | 2 | 53 | $26,435 | $30,218 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $7,779 | 5 payments
|
| GlaxoSmithKline | None | $5,600 | 2 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $155 | 3 payments
|
| Abbvie | Creon | $43 | 2 payments
|
| Genzyme | Dupixent | $41 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
See all 14 published payments
| Gilead Sciences | Paid to speak or teach · 2025-10-07 | None | $3,790 |
| GlaxoSmithKline | Consulting · 2025-08-05 | None | $3,200 |
| Madrigal Pharmaceuticals | Meals · 2025-06-10 | Rezdiffra | $18 |
| Madrigal Pharmaceuticals | Meals · 2025-06-10 | Rezdiffra | $16 |
| Abbvie | Meals · 2025-05-22 | Creon | $23 |
| Madrigal Pharmaceuticals | Meals · 2025-05-21 | Rezdiffra | $122 |
| Abbvie | Meals · 2025-05-08 | Linzess | $20 |
| Gilead Sciences | Paid to speak or teach · 2025-05-01 | None | $3,790 |
| Gilead Sciences | Meals · 2025-05-01 | None | $22 |
| Genzyme | Meals · 2025-04-29 | Dupixent | $41 |
| Gilead Sciences | Meals · 2025-04-16 | None | $150 |
| GlaxoSmithKline | Consulting · 2025-03-18 | None | $2,400 |
| Gilead Sciences | Meals · 2025-02-05 | None | $27 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-01-23 | Xifaxan | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $16,540
| Gilead Sciences | Vemlidy | $12,333 | 14 payments
|
| GlaxoSmithKline | None | $4,000 | 2 payments
|
| Abbvie | Creon | $132 | 10 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $58 | 3 payments
|
| Echosens North America | Fibroscan | $18 | 1 payment
|
2023: $7,479
| Gilead Sciences | Vemlidy | $7,282 | 4 payments
|
| AbbVie | Mavyret | $198 | 11 payments
|
2022: $13,392
| Gilead Sciences | Vemlidy | $13,249 | 11 payments
|
| Abbvie | Mavyret | $143 | 8 payments
|
2021: $20,725
| Gilead Sciences | Epclusa | $20,566 | 24 payments
|
| AbbVie | Mavyret | $159 | 10 payments
|
2020: $22,805
| Gilead Sciences | Epclusa | $20,805 | 26 payments
|
| Mallinckrodt Hospital Products | None | $2,000 | 1 payment
|
2019: $30,218
| Gilead Sciences | Vemlidy | $26,774 | 39 payments
|
| AbbVie | Mavyret | $3,444 | 14 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2024 | Their institution | $168,246 |
| Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2025 | Their institution | $82,234 |
| Gilead Sciences, Inc. · Vemlidy Treatment Effectiveness in Treatment-Naive, Chronic Hepatitis B Asian Pacific Islanders Adults With Normal Alt and Significant Fibrosis in A Community-Based Clinical Setting · 2019 | Their institution | $52,572 |
| Novo Nordisk AS · 2022 | Their institution | $41,765 |
| Novo Nordisk AS · 2021 | Their institution | $40,621 |
| Bausch Health US, LLC · A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (Ssd) for the Delay of Encephalopathy Decompensation in Cirrhosis · 2023 | Their institution | $24,590 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Negative, Chronic Hepatitis B · 2019 | Their institution | $23,030 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Negative, Chronic Hepatitis B · 2020 | Their institution | $17,962 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Negative, Chronic Hepatitis B · 2021 | Their institution | $17,860 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Efficacy and Safety of Tenofovir Alafenamide (Taf) Versus Tenofovir Disoproxil Fumarate (Tdf) in Virologically Suppressed Subjects With Chronic Hbv · 2019 | Their institution | $15,869 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Positive, Chronic Hepatitis B · 2021 | Their institution | $15,185 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Positive, Chronic Hepatitis B · 2019 | Their institution | $14,461 |
| Gilead Sciences, Inc. · Vemlidy Treatment Effectiveness in Treatment-Naive, Chronic Hepatitis B Asian Pacific Islanders Adults With Normal Alt and Significant Fibrosis in A Community-Based Clinical Setting · 2024 | Their institution | $13,000 |
| Gilead Sciences, Inc. · Stellar-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Nonalcoholic Steatohepatitis (Nash) and Bridging (F3) Fibrosis · 2019 | Their institution | $10,407 |
| Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind Study To Evaluate the Safety and Efficacy of Tenofovir Alafenamide (Taf) 25 Mg Qd Versus Tenofovir Disoproxil Fumarate (Tdf) 300 Mg Qd for the Treatment of Hbeag-Positive, Chronic Hepatitis B · 2020 | Their institution | $10,264 |
| Gilead Sciences, Inc. · A Phase 2, Open-Label Study To Evaluate the Safety and Efficacy of Switching To Tenofovir Alafenamide (Taf) From Tenofovir Disoproxil Fumarate (Tdf) and/Or Other Oral Antiviral Treatment (Oav) in Virologically Suppressed Chronic Hepatitis B Subjects With Renal and/Or Hepatic Impairment · 2019 | Their institution | $7,803 |
| Intercept Pharma Europe Ltd. · Randomized Global Phase 3 Study To Evaluate the Impact on Nash With Fibrosis of Obeticholic Acid Treatment (Regenerate) · 2024 | Their institution | $1,940 |
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Age Appropriate Screening ColonoscopyAs Medicare defines this measure | 0% | 1,072 |
| Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsAs Medicare defines this measure | 100% | 320 |
| Colon cancer screeningEligible adults who got a colon cancer test | 100%That's most of the people this applied to. | 1,534 |
| Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate UseAs Medicare defines this measure | 100% | 211 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 2,121 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,847 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Offers telehealth visits
Professional record
- NPI
- 1326041658
- Licence
- CA G61514California G61514: Current · expires 2027-01-31
- Trained
- Northwestern University Feinberg Medical School, 1986
- Group
- Huy N Trinh MD Gastroenterology Hepatology Inc · San Jose Gastroenterology, Inc.
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G61514
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 227 N Jackson Ave Ste 235, San Jose, CA, 95116
- NPI first listed
- 2005-05-31
- NPI last updated
- 2026-01-06
- NPI record certified
- 2026-01-06
This is when the NPI record was last certified, not a medical board exam.